Drug recall · September 21, 2016
DOBUTamine Injection recall
Why: Discoloration: Firm received complaints of product discoloration and particulates.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
DOBUTamine Injection, USP 250 mg/20 mL, 20 mL Vial, For IV Use Only, Must be Diluted Prior to Use, (12.5 mg per mL), Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-2025-20
- Lots / codes
Lot #: 52175DD, Exp 01 Oct 2016
- Quantity
- 24000 vials
- Company
- Hospira Inc., Lake Forest, IL
- Distribution
- Product was distributed nationwide. 23700 units distributed to US and Puerto Rico, and Bahamas was 300 units. 30 units returned by customer and destroyed internally.
- Initiated
- August 15, 2016 · Voluntary: Firm initiated
- Classified
- September 14, 2016
- Reported
- September 21, 2016
- Ended
- August 23, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dobutamine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.